v3.25.4
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Basic EPS        
Net earnings attributable to AbbVie Inc. $ 1,816 $ 4,226 $ 4,278 $ 4,863
Earnings allocated to participating securities   40 40 43
Earnings available to common shareholders   $ 4,186 $ 4,238 $ 4,820
Weighted-average basic shares outstanding (in shares)   1,769 1,769 1,768
Basic earnings per share (in dollars per share) $ 1.02 $ 2.37 $ 2.40 $ 2.73
Diluted EPS        
Net earnings attributable to AbbVie Inc. $ 1,816 $ 4,226 $ 4,278 $ 4,863
Earnings allocated to participating securities   40 40 43
Earnings available to common shareholders   $ 4,186 $ 4,238 $ 4,820
Weighted-average basic shares outstanding (in shares)   1,769 1,769 1,768
Effect of dilutive securities (in shares)   4 4 5
Weighted-average diluted shares outstanding (in shares)   1,773 1,773 1,773
Diluted earnings per share (in dollars per share) $ 1.02 $ 2.36 $ 2.39 $ 2.72